-+ 0.00%
-+ 0.00%
-+ 0.00%

ATYR PHARMA - REGAINS EXCLUSIVE GLOBAL RIGHTS TO EFZOFITIMOD - SEC FILING

Reuters·07/31/2026 20:48:03

Please log in to view news